Latest From Floelle Inc.
This Month's Profile Group: Medtech Start-Ups Innovate in Urinary Incontinence features profiles of Floelle, InControl Medical, NexHand, and Solace Therapeutics. Plus these Start-Ups Across Health Care: Ablative Solutions, Epiomed Therapeutics, Halo Healthcare, and Thrombolytic Science International.
Floelle Inc. is developing a nonsurgical solution for women with stress and mixed urinary incontinence that it thinks will address the drawbacks of current technologies and provide a safe and effective solution that is convenient for patients. The Floelle device resides in the urethra where it allows normal urination, but a pressure-sensitive valve blocks the involuntary urine leaks caused by coughing, laughing, sneezing, and other activities that increase intra-abdominal pressure in women with stress urinary incontinence.
Angel- and venture-backed medtech start-ups are working to fill the tremendous unmet need for alternative device options for treating (not just managing) female urinary incontinence a condition that has a significant impact on quality of life for millions of women. In this issue we profile Floelle, InControl Medical, NexHand, and Solace Therapeutics.
- Implantable Devices
- Therapeutic Areas
- Gynecological, Urological
- North America
- Parent & Subsidiaries
- Floelle Inc.
- Senior Management
- Jerrold M Shapiro, PhD, Pres.
- Contact Info
Phone: (508) 875-3993
100 Powdermill Rd.
Acton, MA 01720-5932
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.